YK-2-69 exhibited much higher anti-PCa efficacy via synergistic regulation on a panel of pathways, including DYRK2-4E-BP1, DYRK2-RRS1-P21/27-CDK4/6, and so on, to promote apoptosis and inhibit proliferation. Here, DYRK2 is linked to posterior cortical atrophy.